Cargando…

Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper

Detalles Bibliográficos
Autores principales:	Belenkaya, Svetlana V., Merkuleva, Iuliia A., Yarovaya, Olga I., Chirkova, Varvara Yu, Sharlaeva, Elena A., Shanshin, Daniil V., Volosnikova, Ekaterina A., Vatsadze, Sergey Z., Khvostov, Mikhail V., Salakhutdinov, Nariman F., Shcherbakov, Dmitriy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Bioengineering and Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658891/ https://www.ncbi.nlm.nih.gov/pubmed/38026885 http://dx.doi.org/10.3389/fbioe.2023.1294266

Ejemplares similares

The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
por: Belenkaya, Svetlana V., et al.
Publicado: (2023)

Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
por: Shcherbakov, Dmitriy, et al.
Publicado: (2021)

Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus
por: Dalinger, A. I., et al.
Publicado: (2023)

Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
por: Baev, Dmitry S., et al.
Publicado: (2022)

Synthesis of conjugates of (aR,7S)-colchicine with monoterpenoids and investigation of their biological activity
por: Shchegravina, E. S., et al.
Publicado: (2023)

Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19
por: Kolosova, Evgeniia A., et al.
Publicado: (2022)

Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus
por: Borisevich, Sophia S., et al.
Publicado: (2023)

(+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
por: Filimonov, Aleksandr S., et al.
Publicado: (2022)

Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Biochemical Properties of a Promising Milk-Clotting Enzyme, Moose (Alces alces) Recombinant Chymosin
por: Balabova, Dina V., et al.
Publicado: (2023)

SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights
por: Borisevich, Sophia S., et al.
Publicado: (2022)

Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Borgoyakova, M. B., et al.
Publicado: (2021)

Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune
por: Timofeeva, Anna M., et al.
Publicado: (2022)

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023)

Synthesis and Antiviral Properties of Camphor-Derived Iminothiazolidine-4-Ones and 2,3-Dihydrothiazoles
por: Oreshko, Vladislav V., et al.
Publicado: (2022)

Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
por: Yarovaya, Olga I., et al.
Publicado: (2022)

Turn Enemies Into Allies
por: Ringer, Judy
Publicado: (2019)

Bornyl Derivatives of p-(Benzyloxy)Phenylpropionic Acid: In Vivo Evaluation of Antidiabetic Activity
por: Kuranov, Sergey, et al.
Publicado: (2020)

Effect of New Antiviral Agent Camphecin on Behavior of Mice
por: Babina, A. V., et al.
Publicado: (2017)

Synthesis and Evaluation of Hypoglycemic Activity of Structural Isomers of ((Benzyloxy)phenyl)propanoic Acid Bearing an Aminobornyl Moiety
por: Kuranov, Sergey O., et al.
Publicado: (2023)

CD4 T Follicular Helper Cells and HIV Infection: Friends or Enemies?
por: Moukambi, Félicien, et al.
Publicado: (2017)

The Study of Hypoglycemic Activity of 7-Terpenylcoumarins
por: Kuranov, Sergey, et al.
Publicado: (2022)

Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?
por: Shanshin, Daniil V., et al.
Publicado: (2022)

Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections
por: Merkuleva, Yu. A., et al.
Publicado: (2022)

Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome
por: Blokhin, Mikhail E., et al.
Publicado: (2023)

Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses
por: Fomenko, Vladislav V., et al.
Publicado: (2022)

Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action
por: Khvostov, Mikhail V., et al.
Publicado: (2021)

Synthesis and Antiviral Activity of Camphene Derivatives against Different Types of Viruses
por: Sokolova, Anastasiya S., et al.
Publicado: (2021)

The effect of thioredoxin and prochymosin coexpression on the refolding of recombinant alpaca chymosin
por: Belenkaya, S.V., et al.
Publicado: (2023)

Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies
por: Pon’kina, Darya A., et al.
Publicado: (2023)

Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus
por: Sokolova, Anastasiya S., et al.
Publicado: (2021)

Camphor-based symmetric diimines as inhibitors of influenza virus reproduction
por: Sokolova, Anastasiya S., et al.
Publicado: (2014)

Invasive Plants: Turning Enemies into Value
por: Máximo, Patrícia, et al.
Publicado: (2020)

Study of Hypoglycemic Activity of Novel 9-N-alkyltetrahydroberberine Derivatives
por: Khvostov, Mikhail V., et al.
Publicado: (2022)

Single-stage synthesis of heterocyclic alkaloid-like compounds from (+)-camphoric acid and their antiviral activity
por: Chernyshov, Vladimir V., et al.
Publicado: (2019)

9-N-n-alkyl Berberine Derivatives: Hypoglycemic Activity Evaluation
por: Khvostov, Mikhail V., et al.
Publicado: (2022)

Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine
por: Pon`kina, Darya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_curf88kuc6474nrp1185856m2f